Results with Lifescozul™
Introduction to the case
Lung Cancer is the type of cancer that claims more lives per year worldwide and is the most common cancer among men and women.
Esthela was diagnosed in November 2015 with a right Lung Cancer with metastasis in multiple locations, including in the brain.
To treat her disease the doctors prescribed chemotherapy and radiotherapy sessions, but still she was not predicted to have more than 6 months to live.
The right apical tumor mass measured 4.5×3.2×2.2 centimeters, and despite receiving chemotherapy the tumor had increased in size in the last two months.
They heard about the LifEscozul treatment (the most effective formulation made from blue scorpion venom) from a family member. Immediately Esthela's son, Humberto, investigated further and found the LifEscozul Group on the internet.
Humberto contacted us and Esthela started treatment with LifEscozul in May 2016. Let's learn more about her case and what her results have been during these 4 years of treatment.
-
Clinical Data
Blanca Esthela García Yáñez, 69 years old at the beginning of treatment with LifEscozul.
-
Symptomatology
Right shoulder pain, rest with medication, on antidepressant. Anemia.
-
Protocol Start
Mayo del 2016.
-
Specialist assigned to Grupo LifEscozul™
Doctor Beatriz Garcia.
-
Diagnostics
Right lung cancer, pretracheal lymph node involvement, pulmonary nodules.
Background
In 2015 Esthela had to undergo some tests for medical insurance, and at the time she had a thoracic x-ray, a shadow appeared in her right lung.
From that finding she underwent more studies and in November 2015 she was diagnosed with Lung Cancer with metastasis in several locations, including the brain.
Her doctor prescribed chemotherapy and radiotherapy sessions, but due to the advanced stage of the disease, she was not predicted to have more than 6 months to live.
Her son, Humberto, seeing the negative prognosis of his mother, decided to look for other treatment options that could help her. Thanks to a family member he heard about LifEscozul (escozul, blue scorpion venom, escoazul), and while searching for more information on the internet he came across the LifEscozul Group.
When he contacted us in May 2016, Esthela presented with a right apical tumor mass measuring 4.5×3.2×2.2 centimeters, which had increased in size over the last two months despite receiving chemotherapy.
It was a pleasant surprise for Humberto to discover that we have a location in Quito, the city where he lives.
Our Medical Team evaluated Esthela's case, she was approved in our Protocol and started treatment with LifEscozul (the most effective formulation made with blue scorpion venom) in May 2016.
When she started with LifEscozul Esthela was already receiving radiotherapy sessions and was pending to start new chemotherapy sessions.
Evolution with LifEscozul™ and actual results
JULY 2016
Since the beginning of our treatment both Esthela and Humberto have maintained constant communication with Dr. Beatriz Garcia, which has allowed us to make the necessary adjustments in the dosage of LifEscozul (escozul, blue scorpion venom, escoazul) to obtain better results.
In July 2016 Esthela underwent a CT scan to evaluate the evolution of her disease. This study reported a decrease in tumor size to 3.4×1.9×2.5 centimeters.
Esthela reported to us that she was in good physical condition and felt more upbeat.
JANUARY TO JUNE 2017
In January 2017 Esthela has a new CT scan, which reported that there was again a decrease in tumor size to 3×1.4×2 centimeters.
It is very important to highlight that since Esthela started with the treatment with LifEscozul (the most effective formulation made with blue scorpion venom), the tumor has decreased by 73.5% in size, proving once again that the use of our treatment in conjunction with other therapies not only helps the patient to feel better but also to have better results.
In the results of the CT scan performed in June 2017 it was found that the only lung nodule that persisted remained stable in size, and its localized metabolic activity had decreased from 3.2 to 1.9, so at this time it is considered that the nodule had no malignant tumor activity.
During these months Esthela reported that she was happy, in excellent spirits and feeling much better physically.
Esthela subsequently underwent surgery to remove the brain tumor.
2018 TO 2020
Esthela's disease remained stable according to her reports to us from 2018 to 2019. She did not present involvement beyond the lung.
The last study performed in June 2020 indicated that the already known residual lesion persists in lung, with diffuse metabolic activity without structural changes and pulmonary nodules without changes or metabolic activity. There is no evidence of locoregional or metastatic tumor activity.
Esthela's results during her 4 years of treatment with LifEscozul (escozul, blue scorpion venom, escoazul) have been very positive:
- It was possible to reverse the increase in the size of the lesion that was being observed, something that was not achieved with the chemotherapy sessions she received in 2015 (let's remember that at that time rather the tumor increased in size).
- There was no further evidence of tumor activity.
- He overcame his initial prognosis of 6 months to live.
Our Medical Team continued with a scheme of progressively increasing doses of LifEscozul (the most effective formulation made with blue scorpion venom), with the intention of maintaining and improving these results.
Esthela did not lose quality of life, she did not lose her hair or weight due to the chemotherapy sessions, and the most important thing is that she did not lose her spirit or her desire to move forward. Today she can enjoy her family and do her activities with total normality.
For the LifEscozul Group, it is very important to point out that it is not possible to generalize any result with LifEscozul (escozul, blue scorpion venom, escoazul) treatment, our goal is not to create false expectations in our patients or their families.
The treatment with LifEscozul does not work miracles, only the joint work and constant communication between our patients and our Medical Team allow us to maintain the doses of LifEscozul (the most effective formulation made with blue scorpion venom) personalized and functional against tumors.
Resumen
In November 2015 Esthela was diagnosed with Lung Cancer. Her disease was very advanced and her doctors gave her no more than 6 months to live.
Despite receiving chemotherapy the right apical tumor mass of 4.5×3.2×2.2 centimeters increased in size, so Esthela's son, Humberto, started looking for other treatment options that would help his mom get better.
On the internet he found LifEscozul Group and in May 2016 Esthela started with LifEscozul treatment (the most effective formulation made with blue scorpion venom).
After 11 months with our treatment the tumor decreased by 73.5% in size. In addition, Esthela did not lose quality of life and remained in very good spirits and health.
From the 6 months of life her doctors predicted for her in 2015, 5 years have already passed, and Esthela has remained in good physical condition despite the different treatments she has undergone.
As we watched her evolution our Medical Team adjusted the doses of LifEscozul (escozul, blue scorpion venom, escoazul), this was thanks to the constant communication that both Esthela and Humberto have maintained with us.
Their case will continue under our medical observation.
We are the LifEscozul Group and the Results Define Us.
Next case
José Ríos
El señor José empezó a tener muchas ganas de orinar por las noches en Diciembre del 2019, por lo que asistió al urólogo para que le realizara los exámenes pertinentes.
Su Antígeno Prostático (PSA) estaba en 100 ng/ml, y luego de una resección trasnuretral y una orquiectomía simple bilateral, patología confirmó que efectivamente se trataba de Cáncer de Próstata.
View more
